New Breakthrough PET/CT and PET/MRI Systems Change Performance
Paradigm
HONOLULU--(BUSINESS WIRE)--
Bruker (NASDAQ: BRKR) today introduced four important new preclinical
imaging systems at the World Molecular Imaging Congress 2015 (WMIC, www.wmis.org)
in Honolulu, Hawaii. The novel products launched at WMIC each deliver
improved performance and convenience for routine imaging, and open new
horizons for advanced translational research, while Bruker’s platform
philosophy facilitates multimodal imaging projects. Researchers will
gain a more complete picture and deeper insights into the causes,
progression, potential diagnosis and treatment of disease, accelerating
the translation of preclinical results to clinical progress.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20150903005040/en/
Next-Generation
Albira™ Si PET/SPECT/CT System
A revolutionary and
proprietary gridless PET detector architecture, which is also available
for Bruker’s new PET/MRI systems, makes the Albira
Si the most advanced and highest performance preclinical PET
system on the market. It delivers, for the first time, sub-millimeter
spatial resolution across the full radial field of view (FOV),
increasing the high-resolution FOV by an order of magnitude compared to
traditional PET systems. This breakthrough capability, combined with
exceptional count rate performance and outstanding PET sensitivity,
makes Albira Si the preferred system for dynamic and gated PET in
vivo studies.
The Albira Si offers all benefits of integration with SPECT and
CT. The micro-CT provides anatomical reference images and attenuation
corrections for PET and SPECT imaging. In addition, the Albira Si
is compatible with Bruker’s Multimodal Animal Beds for cross-platform
MRI and optical molecular imaging.
Professor Jose Benlloch, Director of the Institute for Instrumentation
in Molecular Imaging (I3M) at the Polytechnical University of Valencia
in Spain, explained: “The new Silicon PM detector technology has major
advantages in providing better PET position, energy and timing
resolution, and it is compatible with MRI. An additional significant
benefit of our unique, continuous crystals technology pioneered at I3M,
is the greatly enhanced DOI detection for highest resolution across the
entire field of view, which is very beneficial for virtually all
preclinical PET applications.”
New
BioSpec® 3T Preclinical MRI System with
Superior Cryogen-free Magnet
The new BioSpec 3T
features breakthrough cryogen-free magnet technology that overcomes the
reliability limitations of older cryogen-free magnets that quench within
minutes after power outages or cooling water failures. The BioSpec
3T will remain at field 25x-100x longer after a disruption.
Cryo-cooler maintenance can conveniently be done at field by Bruker’s
magnet service engineers.
The BioSpec 3T features an 18 cm magnet bore, and is upgradable
to PET/MRI. Adding Bruker’s proprietary MRI CyroProbe™ for mice
and rats, MRI sensitivity and spatial resolution can optionally be
increased to be comparable to conventional 7T MRI. The new ParaVision
6 software features validated in vivo protocols, and an
easy-to-use preclinical user interface that unifies workflows across
different modalities, with facile multi-modality image fusion.
Next-Generation
PET/MRI System
Combining the breakthrough Albira Si
PET detector technology with superior MRI soft tissue contrast are now
offered in the new BioSpec 3T PET/MRI,
in one compact instrument. Built-in Multimodal Animal Beds are fully
compatible with other Bruker molecular imaging systems. Other PET/MRI
combinations may be available upon request.
New,
High-Sensitivity Xtreme II Optical Molecular Imaging System
The
integration of a new CCD camera brings a new level of sensitivity, speed
and versatility. By deeper cooling of the camera and low noise
electronics, new levels of performance during low-light applications,
such as bioluminescence and Cerenkov imaging, can now be achieved.
Versatility is maintained with five imaging modalities provided as
standard within the Xtreme
II, allowing for co-registration of molecular events with access
to bioluminescence, multispectral VIS-NIR fluorescence, unique direct
radioisotopic imaging, and Cerenkov radiation. A high speed digital
X-ray scanner with industry-leading resolution and reflectance modes
enhance the optical functional images with morphological features.
Dr. Wulf Jung, President of Bruker’s Preclinical Imaging Division,
commented: “At WMIC 2015, Bruker is demonstrating clear performance
leadership in preclinical PET/CT and PET/MRI, and we are pleased to
respond to our customers’ demand for a translational research 3 Tesla
preclinical MRI with robust cryogen-free magnet technology. Our optical
molecular imaging capabilities have also been further enhanced to meet
customer expectations.”
About Bruker Corporation (NASDAQ: BRKR)
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve the
quality of human life. Bruker’s high-performance scientific research
instruments and high-value analytical solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, productivity and customer success in life science molecular
research, in applied and pharma applications, in microscopy,
nano-analysis and industrial applications, as well as in cell biology,
preclinical imaging, clinical research, microbiology and molecular
diagnostics.
For more information, please visit: www.bruker.com/preclinicalimaging
View source version on businesswire.com: http://www.businesswire.com/news/home/20150903005040/en/
Source: Bruker Corporation